2023 VISION Registry Data Report

II. Quality of Life

Quality of life (QOL) reported by patients with metastatic ocular melanoma living in different countries. 10 responses

98

CANADA (1 response)

82

UNITED STATES (9 responses)

QOL reported by patients with metastatic ocular melanoma at different ages. 11 responses 72 AGE RANGE 30–49 years (1 response)

84

PATIENT VOICE

AGE RANGE 50–69 years (6 responses)

“I’m so grateful to those who created VISION and to those who filled out the outstanding and comprehensive survey! “We have a very rare cancer and rare cancers aren’t lucrative for drug companies, and therefore our cancers don’t get as much funding, research, and treatments discoveries as cancers with a huge population. “Therefore, we all want to do everything we can to support this thorough survey, which will enable researchers to study us and move closer to cures. “Thank you for your part in making all that happen!” — VISION Participant in USA

85

AGE RANGE 70+ years (4 responses)

QOL SCORE RANGE: 0–108 The higher the score, the better the patient’s reported quality of life.

2023 VISION Registry Data Report

35

Made with FlippingBook Ebook Creator